DANAHER CORPORATION's ticker is DHR and the CUSIP is 235851102. A total of 2,042 filers reported holding DANAHER CORPORATION in Q3 2023. The put-call ratio across all filers is 0.89 and the average weighting 0.6%.
About DANAHER CORPORATION
Danaher Corporation is a global science and technology company that designs, manufactures, and markets innovative products and services to professional, medical, industrial, and commercial customers. The company operates through four segments: Life Sciences, Diagnostics, Dental, and Environmental & Applied Solutions.
Danaher's Life Sciences segment provides a range of research tools to scientists around the world, including mass spectrometry, chromatography, and automation systems. The Diagnostics segment offers a broad range of diagnostic products, including clinical chemistry, immunoassay, microbiology, and molecular diagnostic systems. The Dental segment provides a range of dental equipment and consumables, including imaging systems, dental instruments, and consumables. The Environmental & Applied Solutions segment offers a range of products and services to help customers protect the environment and improve productivity.
Danaher has a strong track record of growth and innovation, driven by its focus on continuous improvement and customer satisfaction. The company has a culture of operational excellence, which has enabled it to consistently deliver high-quality products and services to its customers. Danaher's management team is highly experienced and has a proven track record of creating value for shareholders.
In conclusion, Danaher Corporation is a well-established and innovative company that is well-positioned to continue delivering strong growth and value to its shareholders. With its focus on operational excellence and customer satisfaction, Danaher is a company that investors should keep an eye on.
It's important to note that this information is for educational purposes only and has not been fact-checked. As with any investment, it's important to do your own research and consult with a financial advisor before making any investment decisions.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q3 2023 | $451,745 | +5.0% | 1,820,817 | +1.6% | 0.99% | +8.7% |
| Q2 2023 | $430,237 | +14.3% | 1,792,650 | +20.1% | 0.91% | +2.2% |
| Q1 2023 | $376,276 | -11.3% | 1,492,922 | -6.6% | 0.89% | -13.6% |
| Q4 2022 | $424,104 | -99.9% | 1,597,866 | -16.0% | 1.03% | -19.4% |
| Q3 2022 | $491,295,000 | +1.3% | 1,902,108 | -0.5% | 1.28% | +6.0% |
| Q2 2022 | $484,758,000 | -13.6% | 1,912,113 | -0.1% | 1.21% | +2.7% |
| Q1 2022 | $561,161,000 | -9.2% | 1,913,073 | +1.9% | 1.18% | -4.9% |
| Q4 2021 | $617,920,000 | +9.8% | 1,878,124 | +1.6% | 1.24% | +3.2% |
| Q3 2021 | $562,710,000 | +14.5% | 1,848,346 | +0.9% | 1.20% | +12.5% |
| Q2 2021 | $491,422,000 | +21.2% | 1,831,209 | +1.7% | 1.07% | +9.9% |
| Q1 2021 | $405,349,000 | -11.9% | 1,800,912 | -13.0% | 0.97% | -19.8% |
| Q4 2020 | $459,979,000 | -21.4% | 2,070,672 | -23.8% | 1.21% | -30.0% |
| Q3 2020 | $585,209,000 | +20.8% | 2,717,726 | -0.8% | 1.73% | +13.1% |
| Q2 2020 | $484,392,000 | +30.4% | 2,739,315 | +2.0% | 1.53% | +2.2% |
| Q1 2020 | $371,548,000 | -12.2% | 2,684,398 | -2.6% | 1.50% | +9.2% |
| Q4 2019 | $423,175,000 | +5.0% | 2,757,196 | -1.2% | 1.37% | -4.7% |
| Q3 2019 | $402,884,000 | +1.1% | 2,789,469 | +0.1% | 1.44% | +7.2% |
| Q2 2019 | $398,462,000 | +17.1% | 2,788,007 | +8.2% | 1.34% | +2.8% |
| Q1 2019 | $340,282,000 | +21.9% | 2,577,501 | -4.7% | 1.31% | +7.5% |
| Q4 2018 | $279,040,000 | -17.2% | 2,705,976 | -12.7% | 1.22% | -3.1% |
| Q3 2018 | $336,920,000 | -3.7% | 3,100,672 | -12.6% | 1.25% | -7.6% |
| Q2 2018 | $349,899,000 | +1.0% | 3,545,786 | +0.2% | 1.36% | +0.7% |
| Q1 2018 | $346,471,000 | +6.6% | 3,538,663 | +1.1% | 1.35% | +6.9% |
| Q4 2017 | $324,869,000 | +8.2% | 3,499,983 | +0.0% | 1.26% | +5.3% |
| Q3 2017 | $300,135,000 | +16.7% | 3,498,892 | +14.8% | 1.20% | +15.5% |
| Q2 2017 | $257,212,000 | -1.0% | 3,047,895 | +0.3% | 1.04% | -4.4% |
| Q1 2017 | $259,875,000 | +22517.5% | 3,038,383 | +20467.1% | 1.08% | +21580.0% |
| Q4 2016 | $1,149,000 | +101.9% | 14,773 | +103.4% | 0.01% | +66.7% |
| Q3 2016 | $569,000 | -89.6% | 7,262 | -86.6% | 0.00% | -90.0% |
| Q2 2016 | $5,483,000 | -1.7% | 54,299 | -7.6% | 0.03% | -3.2% |
| Q1 2016 | $5,577,000 | -16.2% | 58,795 | -17.9% | 0.03% | -16.2% |
| Q4 2015 | $6,653,000 | +16.1% | 71,638 | +6.6% | 0.04% | +12.1% |
| Q3 2015 | $5,728,000 | -18.5% | 67,217 | -18.1% | 0.03% | -10.8% |
| Q2 2015 | $7,025,000 | -25.2% | 82,076 | -25.8% | 0.04% | -22.9% |
| Q1 2015 | $9,392,000 | -9.1% | 110,629 | -8.2% | 0.05% | -14.3% |
| Q4 2014 | $10,334,000 | -12.0% | 120,567 | -22.0% | 0.06% | +60.0% |
| Q3 2014 | $11,749,000 | +60.5% | 154,633 | +66.3% | 0.04% | -22.2% |
| Q2 2014 | $7,322,000 | +5.6% | 92,997 | +0.6% | 0.04% | -4.3% |
| Q1 2014 | $6,933,000 | -9.3% | 92,431 | -6.6% | 0.05% | -14.5% |
| Q4 2013 | $7,642,000 | +11.4% | 98,972 | +0.0% | 0.06% | -1.8% |
| Q3 2013 | $6,858,000 | +373.3% | 98,930 | +332.2% | 0.06% | +330.8% |
| Q2 2013 | $1,449,000 | – | 22,891 | – | 0.01% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| Defender Capital, LLC. | 149,732 | $49,263,000 | 15.79% |
| ARTHUR M. COHEN & ASSOCIATES, LLC | 257,846 | $84,834,000 | 15.76% |
| Riverstone Advisors, LLC | 64,448 | $21,204,000 | 9.33% |
| Eos Focused Equity Management, L.P. | 34,026 | $11,195,000 | 8.72% |
| Mirova US LLC | 1,152,609 | $379,219,000 | 7.12% |
| Lincoln Capital LLC | 83,275 | $27,398,000 | 6.78% |
| CORTLAND ASSOCIATES INC/MO | 197,469 | $64,969,000 | 6.75% |
| Third Point | 2,900,000 | $954,129,000 | 6.66% |
| Front Street Capital Management, Inc. | 117,523 | $36,073,000 | 6.65% |
| Alphinity Investment Management Pty Ltd | 865,427 | $284,734,000 | 6.40% |